CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Hepatitis A - Management
Who should be offered vaccination for hepatitis A?
- Pre-exposure vaccination is recommended for:
- Travellers 1 year of age and older travelling to areas where hepatitis A is moderately or highly endemic, particularly if standards of sanitation and food hygiene are likely to be poor, or if visiting friends and relatives.
- For country-by-country recommendations for hepatitis A and other travel vaccines, see www.nathnac.org.
- People with chronic liver disease, including those with chronic hepatitis B or C (vaccination against hepatitis B is also recommended for non-immune people with hepatitis C).
- People with clotting factor disorders (vaccination against hepatitis B is also recommended).
- Men who have sex with men and people whose sexual behaviour is likely to put them at increased risk (vaccination against hepatitis B is also recommended).
- Injecting drug users (vaccination against hepatitis B is also recommended).
- Individuals at occupational risk
- Laboratory workers who may be exposed to hepatitis A in the course of their work (such as in microbiology laboratories and clinical infectious disease units).
- Staff of large residential institutions (where standards of personal hygiene among residents may be poor).
- Sewage workers at risk of repeated exposure to raw sewage.
- People who work with primates that are susceptible to hepatitis A infection.
- People infected with HIV that belong to a group at risk of the infection or its complications.
- For information on how to vaccinate, see Prescribing information.
© NHS Institute for Innovation and Improvement